An investigation of the efficacy of a polyvalent mastitis vaccine using different vaccination regimens under field conditions in the United King dom

被引:59
作者
Bradley, A. J. [1 ,2 ]
Breen, J. E. [1 ,2 ]
Payne, B. [1 ]
White, V. [1 ]
Green, M. J. [2 ]
机构
[1] Qual Milk Management Serv Ltd, Somerset BA5 1DU, England
[2] Univ Nottingham, Sch Vet Med & Sci, Loughborough LE12 5RD, Leics, England
关键词
vaccination; mastitis; milk production; coliform; Escherichia coli; FLIGHT MASS-SPECTROMETRY; MILK-PRODUCTION CHANGE; CONTROL DAIRY-CATTLE; ESCHERICHIA-COLI; CLINICAL MASTITIS; ANTIBODY-RESPONSES; J5; VACCINATE; DRY PERIOD; COWS; CHALLENGE;
D O I
10.3168/jds.2014-8332
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Vaccination can play a useful role in mastitis control programs, although there is a relative dearth of large, well-controlled field efficacy studies. This paper presents the findings on the use of a commercially available vaccine (Startvac, Hipra UK Ltd., Nottingham, UK) on commercial units under UK field conditions. In total, 3,130 cows were recruited from 7 farms and were randomly allocated, within farm, to 1 of 3 groups. The first group received the vaccine following the label regimen, the second group was vaccinated every 90 d following an initial vaccination course, and the third group was left unvaccinated to act as controls. Vaccine efficacy was assessed in the first 120 d of lactation. Data were available for analysis from 1,696 lactations in 1,549 cows. In total, 779 cases of clinical mastitis occurred in the 3 study groups, and we detected no significant difference in the incidence or prevalence of clinical or subclinical mastitis between any of the 3 groups. Mastitis vaccination following the label regimen was associated with a significant reduction in the severity of clinical cases. Cows in this group were at significantly decreased odds of developing clinical mastitis presenting with more than just milk changes [odds ratio: 0.58; 95% confidence interval (CI): 0.35-0.98]. Similarly, each additional vaccination resulted in a cow being at decreased odds of developing clinical mastitis presenting with more than just milk changes (odds ratio: 0.87; 95% CI: 0.77-0.98). Although no cows were culled because of severe mastitis in either of the vaccinated groups, we detected no significant difference in the mastitis-related culling rate between groups. Analysis of milk production data demonstrated that, on average, cows on the label regimen produced a higher volume of milk (231 L; 95% CI: 104.1-357.4) and more milk solids (12.36 kg; 95% CI: 3.12-21.60) than unvaccinated cows in the first 120 d of lactation. Conservative analysis suggested that a return on investment of 2.57:1 could be expected under UK conditions based on increased milk yield alone.
引用
收藏
页码:1706 / 1720
页数:15
相关论文
共 33 条
[11]   Effect of hyperimmunization with an Escherichia coli J5 bacterin in adult lactating dairy cows [J].
Erskine, Ronald J. ;
VanDyk, Elizabeth J. ;
Bartlett, Paul C. ;
Burton, Jeanne L. ;
Boyle, Michael C. .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2007, 231 (07) :1092-1097
[12]  
Goldstein H., 2010, Multilevel statistical models, V4th
[13]  
GONZALEZ RN, 1989, CAN J VET RES, V53, P301
[14]   Cow, farm, and herd management factors in the dry period associated with raised somatic cell counts in early lactation [J].
Green, M. J. ;
Bradley, A. J. ;
Medley, G. F. ;
Browne, W. J. .
JOURNAL OF DAIRY SCIENCE, 2008, 91 (04) :1403-1415
[15]   National intervention study of mastitis control in dairy herds in England and Wales [J].
Green, M. J. ;
Leach, K. A. ;
Breen, J. E. ;
Green, L. E. ;
Bradley, A. J. .
VETERINARY RECORD, 2007, 160 (09) :287-+
[16]   The use of Markov chain Monte Carlo for analysis of correlated binary data: patterns of somatic cells in milk and the risk of clinical mastitis in dairy cows [J].
Green, MJ ;
Burton, PR ;
Green, LE ;
Schukken, YH ;
Bradley, AJ ;
Peeler, EJ ;
Medley, GF .
PREVENTIVE VETERINARY MEDICINE, 2004, 64 (2-4) :157-174
[17]   Evaluation of an alternative dosing regimen of a J-5 mastitis vaccine against intramammary Escherichia coli challenge in nonlactating late-gestation dairy cows [J].
Gurjar, Abhijit A. ;
Klaessig, Suzanne ;
Salmon, Sarah A. ;
Yancey, Robert J., Jr. ;
Schukken, Ynte H. .
JOURNAL OF DAIRY SCIENCE, 2013, 96 (08) :5053-5063
[18]   STUDY DESIGNS FOR DEPENDENT HAPPENINGS [J].
HALLORAN, ME ;
STRUCHINER, CJ .
EPIDEMIOLOGY, 1991, 2 (05) :331-338
[19]   EFFICACY OF AN ESCHERICHIA-COLI J5 MASTITIS VACCINE IN AN EXPERIMENTAL CHALLENGE TRIAL [J].
HOGAN, JS ;
WEISS, WP ;
TODHUNTER, DA ;
SMITH, KL ;
SCHOENBERGER, PS .
JOURNAL OF DAIRY SCIENCE, 1992, 75 (02) :415-422
[20]  
International Dairy Federation, 1981, BULLETIN, V132